Эффективность фенспирида при бронхиальной астме и хронических неспецифических инфекционно-воспалительных бронхолегочных заболеваниях у детей
С. В. Лукьянов, Середа Елена Васильевна, О Ф Лукина et al. · CyberLeninK (CyberLeninka) · 2003
The authors followed up a total of ninety-eight 4-to-15-year-old children treated with fenspiride. Of these, 35 children suffered from mild bronchial asthma, and 63 subjects had chronic nonspecific infectious-and-inflammatory bronchopulmonary diseases. The control group was composed of 20 children with chronic bronchopulmonary diseases, who did not receive fenspiride. Treatment with fenspiride was accompanied by a decrease in clinical symptoms of bronchial obstruction and improved indices of the external-respiration function in the both groups of the patients, a decrease in sensitivity of H 1-histaminic receptors and lower calcium response to stimulation with histamine and norepinephrine in bronchial asthma, and, to a lesser degree, to stimulation with histamine in chronic bronchopulmonary pathology. Correlation was observed between the histamineand norepinephrine-stimulated intracellular concentration of Ca ions and elevated indices of the external-respiration function in the children suffering from bronchial asthma treated with fenspiride. Conclusion: fenspiride can be used as an alternative drug for basic therapy in mild course of bronchial asthma, especially with a concomitant ARVI, and as an additional means in comprehensive treatment of acute exacerbations of chronic bronchopulmonary diseases in children.
Cited by 0 works.